April 21, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Baxter International Inc (NYSE:BAX) shares over potential securities laws violations by Baxter International Inc and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Baxter International Inc (NYSE:BAX) concerning whether a series of statements by Baxter International Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Baxter International Inc reported that its annual Total Revenue rose from over $9.96 billion in 2015 to over $10.16 billion in 2016 and that its Net Income increased from $393 million in 2015 to over $4.96 billion in 2016.

Shares of Baxter International Inc (NYSE:BAX) grew fro $33.21 per share in October 2015 to as high as $53.54 per share on April 12, 2017.

On April 14, 2017, Baxter International Inc disclosed that an employee of the Company had received a grand jury subpoena related to a criminal investigation by the Antitrust Division of the U.S. Department of Justice into the Company's sales practices of intravenous saline.

On April 21, 2017, NYSE:BAX shares closed at $52.88 per share.